All News

    SLS009 May Improve Survival in R/R AML

    April 8th 2025, 3:00pm

    Article

    SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

    A Patient Shares Insights on Kidney Cancer Awareness and Advocacy

    April 8th 2025, 1:46pm

    Article

    Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and patient advocacy.

    Bavencio Has Long-Term Benefit Regardless of Diabetes Status in Bladder Cancer

    April 7th 2025, 9:00pm

    Article

    Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.

    Raising Awareness for Kidney Cancer and the Challenges Patients Face

    April 7th 2025, 8:00pm

    Video

    It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.

    Shorter Radiation Courses May Improve Breast Reconstruction Outcomes

    April 7th 2025, 7:00pm

    Video

    Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.

    How ‘Man in the Mirror’ Reflects a Cancer Journey

    April 7th 2025, 5:00pm

    Article

    I always wanted to make a difference, but I never expected my biggest impact to come through cancer.

    BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer

    April 7th 2025, 3:00pm

    Article

    The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.

    How Biomarker Testing Can Shape a Breast Cancer Treatment Plan

    April 7th 2025, 1:00pm

    Video

    Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

    Raising Awareness for Lymphedema Following a Cancer Diagnosis

    April 6th 2025, 6:00pm

    Article

    Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.

    FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer

    April 6th 2025, 2:00pm

    Article

    FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.